Supernus Pharmaceuticals Inc. | Small-cap | Healthcare
$31.82
0.95%
| Supernus Stock Comparison:
Supernus vs ZoetisSupernus vs Haleon Plc - ADRSupernus vs Indivior PLCSupernus vs Bausch HealthSupernus vs Ani PharmaceuticalsSupernus vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 661.8M
Gross Profit 583.9M 88.23%
Operating Income 75.6M 11.42%
Net Income 73.9M 11.16%
EPS (Diluted) $1.32

Balance Sheet Metrics

Total Assets 1.4B
Total Liabilities 332.3M
Shareholders Equity 1.0B
Debt to Equity 0.32

Cash Flow Metrics

Operating Cash Flow 166.2M
Free Cash Flow 171.2M

Revenue & Profitability Trend

Supernus Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 661.8M 607.5M 667.2M 579.8M 520.4M
Cost of Goods Sold 77.9M 83.8M 87.2M 75.1M 52.5M
Gross Profit 583.9M 523.7M 580.0M 504.7M 467.9M
Research & Development 108.8M 91.6M 74.6M 90.5M 76.0M
Selling, General & Administrative 321.6M 336.4M 377.2M 304.8M 200.7M
Other Operating Expenses 78.0M 82.4M 82.6M 30.0M 15.7M
Total Operating Expenses 508.4M 510.3M 534.4M 425.2M 292.3M
Operating Income 75.6M 13.4M 45.6M 79.5M 175.6M
Pre-tax Income 97.9M 2.8M 60.7M 73.2M 168.6M
Income Tax 24.0M 1.5M 32.0K 19.8M 41.7M
Net Income 73.9M 1.3M 60.7M 53.4M 127.0M
EPS (Diluted) $1.32 $0.02 $1.04 $0.98 $2.36

Income Statement Trend

Supernus Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 686.1M 493.1M 734.2M 601.6M 630.4M
Non-Current Assets 682.0M 784.6M 968.4M 1.1B 873.7M
Total Assets 1.4B 1.3B 1.7B 1.7B 1.5B
Liabilities
Current Liabilities 292.4M 290.2M 688.0M 315.4M 245.1M
Non-Current Liabilities 39.9M 66.0M 128.3M 557.9M 514.1M
Total Liabilities 332.3M 356.2M 816.3M 873.3M 759.2M
Equity
Total Shareholders Equity 1.0B 921.5M 886.2M 815.9M 744.9M

Balance Sheet Composition

Supernus Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income 73.9M 1.3M 60.7M 53.4M 127.0M
Operating Cash Flow 166.2M 88.7M 82.4M 131.0M 145.7M
Investing Activities
Capital Expenditures -725.0K -551.0K -412.0K -2.0M -3.7M
Investing Cash Flow -189.9M 268.7M -216.7M -94.8M -19.9M
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow 12.2M -893.4M -10.5M -130.4M 3.6M
Free Cash Flow 171.2M 110.5M 116.4M 125.1M 134.7M

Cash Flow Trend

Supernus Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 28.53
Forward P/E 16.76
Price to Book 1.72
Price to Sales 2.65
PEG Ratio 16.76

Profitability Ratios

Profit Margin 9.27%
Operating Margin -4.67%
Return on Equity 6.32%
Return on Assets 2.76%

Financial Health

Current Ratio 2.44
Debt to Equity 3.13
Beta 0.71

Per Share Data

EPS (TTM) $1.11
Book Value per Share $18.41
Revenue per Share $12.07

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
supn 1.8B 28.53 1.72 6.32% 9.27% 3.13
Zoetis 70.3B 28.34 15.12 52.09% 27.12% 145.63
Haleon Plc - ADR 47.2B 25.01 5.88 8.95% 12.84% 63.41
Indivior PLC 1.7B 530.50 -6.04 -0.57% -5.30% -1.29
Bausch Health 2.3B -47.00 -9.23 14.29% -0.41% -89.63
Ani Pharmaceuticals 1.4B 51.63 3.16 -4.57% -3.12% 142.03

Financial data is updated regularly. All figures are in the company's reporting currency.